This group of people is less likely to lose weight on Ozempic

What’s feeding your hunger?

New research suggests that your motivation for eating that second slice of pizza could influence how well you respond to blockbuster GLP-1s like Ozempic and Wegovy.

The study sheds new light on why some people lose up to 20% of their body weight on these drugs — while others barely budge the scale. 3

That’s no small matter: nearly three-quarters of US adults are considered overweight or obese, putting them at higher risk for a host of chronic health problems.

In recent years, roughly 12% of Americans have turned to GLP-1s for weight loss — and their popularity shows no signs of slowing.

“Pre-treatment assessment of eating behavior patterns may help predict who will benefit most,” Professor Daisuke Yabe of Kyoto University, the study’s senior autho